Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-17 Sale | 2024-12-18 8:52 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 3,800 | $31.1 | $118,172 | 393,292 (Direct) | View |
| 2024-12-10 Sale | 2024-12-12 8:44 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 4,818 | $30.91 | $148,934 | 317,092 (Direct) | View |
| 2024-09-10 Sale | 2024-09-13 5:11 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 537 | $26.18 | $14,059 | 180,705 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 6:06 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 2,380 | $22.64 | $53,886 | 180,178 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:42 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 619 | $28.33 | $17,536 | 182,558 (Direct) | View |
| 2023-12-14 Sale | 2023-12-18 8:29 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 514 | $20.76 | $10,671 | 182,672 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:30 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 531 | $50.34 | $26,731 | 150,689 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 5:46 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 78,200 | $54.78 | $4,284,066 | 154,016 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:35 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 509 | $55.16 | $28,076 | 189,420 (Direct) | View |
| 2022-12-28 Sale | 2022-12-30 4:26 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 22,016 | $50.97 | $1,122,125 | 330,882 (Direct) | View |
| 2022-11-15 Sale | 2022-11-16 7:15 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 7,085 | $45.28 | $320,806 | 183,837 (Direct) | View |
| 2022-10-25 Sale | 2022-10-27 9:27 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 15,415 | $45.07 | $694,782 | 314,930 (Direct) | View |
| 2022-09-13 Sale(A) | 2022-10-27 9:23 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 22,500 | $29.18 | $656,550 | 296,593 (Direct) | View |
| 2022-10-06 Sale | 2022-10-07 6:00 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 22,500 | $39.29 | $884,025 | 247,665 (Direct) | View |
| 2022-09-30 Sale | 2022-10-04 8:57 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 45,000 | $32.72 | $1,472,400 | 336,593 (Direct) | View |
| 2022-09-13 Sale | 2022-09-15 7:56 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 22,500 | $29.18 | $656,550 | 223,837 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-17 Exercise | 2024-12-18 8:52 pm | N/A 2033-12-08 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 3,800 | $0 | 393,292 (Direct) | View |
| 2024-12-16 Option Award | 2024-12-18 8:52 pm | N/A 2034-12-15 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 80,000 | $0 | 393,292 (Direct) | View |
| 2024-12-17 Exercise | 2024-12-18 8:52 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 3,800 | $19.87 | 393,292 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 8:44 pm | N/A 2033-12-08 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 2,450 | $0 | 317,092 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 8:44 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 2,450 | $19.87 | 317,092 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,064 | $19.94 | 181,242 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:38 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 178,734 | $0 | 329,423 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:46 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 40,000 | $0 | 154,016 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:46 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 40,000 | $0.61 | 154,016 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 4:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 603 | $43.47 | 189,929 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 4:26 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 9,516 | $0 | 330,882 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 4:26 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 9,516 | $28.35 | 330,882 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 7:47 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 29,073 | $0 | 87,221 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:30 pm | N/A 2032-12-08 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 105,574 | $0 | 289,411 (Direct) | View |
| 2022-10-25 Exercise | 2022-10-27 9:27 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 10,000 | $0 | 314,930 (Direct) | View |
| 2022-10-25 Exercise | 2022-10-27 9:27 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,797 | $28.35 | 314,930 (Direct) | View |
| 2022-10-25 Exercise | 2022-10-27 9:27 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 8,203 | $6.36 | 314,930 (Direct) | View |
| 2022-09-13 Exercise(A) | 2022-10-27 9:23 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 10,000 | $0 | 296,593 (Direct) | View |
| 2022-09-13 Exercise(A) | 2022-10-27 9:23 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 10,000 | $6.36 | 296,593 (Direct) | View |
| 2022-10-06 Exercise | 2022-10-07 6:00 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 10,000 | $0 | 247,665 (Direct) | View |
| 2022-10-06 Exercise | 2022-10-07 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 10,000 | $21.09 | 247,665 (Direct) | View |
| 2022-09-30 Exercise | 2022-10-04 8:57 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 20,000 | $0 | 336,593 (Direct) | View |
| 2022-09-30 Exercise | 2022-10-04 8:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 13,672 | $21.09 | 336,593 (Direct) | View |
| 2022-09-30 Exercise | 2022-10-04 8:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 6,328 | $6.36 | 336,593 (Direct) | View |
| 2022-09-09 Option Award | 2022-09-13 9:14 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 58,148 | $0 | 333,559 (Direct) | View |
| 2021-06-30 Option Award | 2022-09-13 9:14 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,007 | $21.09 | 333,559 (Direct) | View |
| 2022-06-30 Option Award | 2022-09-13 9:14 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,152 | $8.03 | 333,559 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:07 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 87,221 | $0 | 87,221 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:49 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 77,580 | $0 | 321,758 (Direct) | View |
| 2020-06-30 Option Award | 2020-12-09 8:49 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,245 | $17.07 | 321,758 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-13 7:04 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 50,024 | $0 | 379,997 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-13 7:04 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 50,024 | $0.61 | 379,997 (Direct) | View |